PROEMEND for I. V. Infusion 150 mg (プロイメンド点滴静注用150mg)

Țară: Japonia

Limbă: engleză

Sursă: すりの適正使用協議会 RAD-AR Council, Japan

Ingredient activ:

Fosaprepitant meglumine

Disponibil de la:

Ono Pharmaceutical Co., Ltd.

INN (nume internaţional):

Fosaprepitant meglumine

Forma farmaceutică:

injection

Prospect

Drug Information Sheet("Kusuri-no-Shiori")
Injection
Published: 06/2022
The information on this sheet is based on approvals granted by the
Japanese regulatory authority. Approval
details may vary by country. Medicines have adverse reactions (risks)
as well as efficacies (benefits). It is
important to minimize adverse reactions and maximize efficacy. To
obtain a better therapeutic response,
patients should understand their medication and cooperate with the
treatment.
BRAND NAME:
PROEMEND FOR I. V. INFUSION 150 MG
ACTIVE INGREDIENT:
Fosaprepitant meglumine
DOSAGE FORM:
injection
IMPRINT OR PRINT ON WRAPPING:
EFFECTS OF THIS MEDICINE
This medicine suppresses nausea and vomiting by suppressing central
emetic response.
It is usually used to prevent digestive symptoms such as nausea and
vomiting caused by anti-
cancer agents.
THE FOLLOWING PATIENTS MAY NEED TO BE CAREFUL WHEN USING THIS
MEDICINE.BE SURE TO TELL YOUR DOCTOR
AND PHARMACIST.
・If you have previously experienced any allergic reactions (itch,
rash, etc.) to any medicines
or foods.
・If you are pregnant or breastfeeding.
・If you are taking any other medicinal products. (Some medicines may
interact to enhance or
diminish medicinal effects. Beware of over-the-counter medicines and
dietary supplements
as well as other prescription medicines.)
DOSING SCHEDULE (HOW TO TAKE THIS MEDICINE)
・
Your dosing schedule prescribed by your doctor is((         

to be written by a healthcare
professional
))
・In general, for adults and children (including infants over 6
months of age), administer by
intravenous infusion once on the first day of treatment with
anti-cancer agents.
・In general, for adults and children over 12 years old, inject over
30 minutes, 1 hour before
the treatment with anti-cancer agents. For infants over 6 months of
age and children under
12 year old, inject over 6 minutes, 1 and half hours before the
treatment with anti-cancer
agents.
PRECAUTIONS WHILE TAKING THIS MEDICINE
POSSIBLE ADVERSE REACTIONS TO THIS MED